[1] |
SUNG H, FERLAY J, SIEGEL R L, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries[J]. CA Cancer J Clin, 2021, 71(3): 209-249.
doi: 10.3322/caac.v71.3
|
[2] |
FERLAY J, STELIAROVA-FOUCHER E, LORTET-TIEULENT J, et al. Cancer incidence and mortality patterns in Europe: estimates for 40 countries in 2012[J]. Eur J Cancer, 2013, 49(6): 1374-1403.
doi: 10.1016/j.ejca.2012.12.027
pmid: 23485231
|
[3] |
SHAH M A, KELSEN D P. Gastric cancer: a primer on the epidemiology and biology of the disease and an overview of the medical management of advanced disease[J]. J Natl Compr Canc Netw, 2010, 8(4): 437-447.
doi: 10.6004/jnccn.2010.0033
|
[4] |
CONDE MONROY D, IBAÑEZ-PINILLA M, SABOGAL J C, et al. Survival outcomes of hepatectomy in gastric cancer liver metastasis: a systematic review and meta-analysis[J]. J Clin Med, 2023, 12(2): 704.
doi: 10.3390/jcm12020704
|
[5] |
GARANCINI M, UGGERI F, DEGRATE L, et al. Surgical treatment of liver metastases of gastric cancer: is local treatment in a systemic disease worthwhile?[J]. HPB (Oxford), 2012, 14(3): 209-215.
doi: 10.1111/j.1477-2574.2011.00428.x
|
[6] |
MIKI Y, FUJITANI K, HIRAO M, et al. Significance of surgical treatment of liver metastases from gastric cancer[J]. Anticancer Res, 2012, 32(2): 665-670.
pmid: 22287760
|
[7] |
ROMANO F, GARANCINI M, UGGERI F, et al. Surgical treatment of liver metastases of gastric cancer: state of the art[J]. World J Surg Oncol, 2012, 10: 157.
doi: 10.1186/1477-7819-10-157
pmid: 22862882
|
[8] |
CHEN L, SONG M Q, LIN H Z, et al. Chemotherapy and resection for gastric cancer with synchronous liver metastases[J]. World J Gastroenterol, 2013, 19(13): 2097-2103.
doi: 10.3748/wjg.v19.i13.2097
|
[9] |
FUJITANI K, YANG H K, MIZUSAWA J, et al. Gastrectomy plus chemotherapy versus chemotherapy alone for advanced gastric cancer with a single non-curable factor (REGATTA): a phase 3, randomised controlled trial[J]. Lancet Oncol, 2016, 17(3): 309-318.
doi: S1470-2045(15)00553-7
pmid: 26822397
|
[10] |
GRANIERI S, ALTOMARE M, BRUNO F, et al. Surgical treatment of gastric cancer liver metastases: systematic review and meta-analysis of long-term outcomes and prognostic factors[J]. Crit Rev Oncol Hematol, 2021, 163: 103313.
doi: 10.1016/j.critrevonc.2021.103313
|
[11] |
MINCIUNA C E, TUDOR S, MICU A, et al. Safety and efficacy of simultaneous resection of gastric carcinoma and synchronous liver metastasis-a western center experience[J]. Medicina (Kaunas), 2022, 58(12): 1802.
|
[12] |
YAMAGUCHI T, TAKASHIMA A, NAGASHIMA K, et al. Evaluating the efficacy of post-operative chemotherapy after curative resection of stage Ⅳ gastric cancer with synchronous oligo metastasis: a multicenter retrospective study[J]. Gastric Cancer, 2023, 26(2): 307-316.
doi: 10.1007/s10120-023-01363-8
|
[13] |
CUI J K, LIU M, SHANG X K. Hepatectomy for liver metastasis of gastric cancer: a meta-analysis[J]. Surg Innov, 2019, 26(6): 692-697.
doi: 10.1177/1553350619856491
|
[14] |
OCHIAI T, SASAKO M, MIZUNO S, et al. Hepatic resection for metastatic tumours from gastric cancer: analysis of prognostic factors[J]. Br J Surg, 1994, 81(8): 1175-1178.
doi: 10.1002/bjs.1800810832
|
[15] |
MARTE G, TUFO A, STECCANELLA F, et al. Efficacy of surgery for the treatment of gastric cancer liver metastases: a systematic review of the literature and meta-analysis of prognostic factors[J]. J Clin Med, 2021, 10(5): 1141.
doi: 10.3390/jcm10051141
|
[16] |
OHKURA Y, SHINOHARA H, HARUTA S, et al. Hepatectomy offers superior survival compared with non-surgical treatment for≤3 metastatic tumors with diameters < 3 cm from gastric cancer: a retrospective study[J]. World J Surg, 2015, 39(11): 2757-2763.
doi: 10.1007/s00268-015-3151-0
|
[17] |
OKI E, TOKUNAGA S, EMI Y, et al. Surgical treatment of liver metastasis of gastric cancer: a retrospective multicenter cohort study (KSCC1302)[J]. Gastric Cancer, 2016, 19(3): 968-976.
doi: 10.1007/s10120-015-0530-z
pmid: 26260876
|
[18] |
WANG Y N, SHEN K T, LING J Q, et al. Prognostic analysis of combined curative resection of the stomach and liver lesions in 30 gastric cancer patients with synchronous liver metastases[J]. BMC Surg, 2012, 12: 20.
doi: 10.1186/1471-2482-12-20
|
[19] |
KINOSHITA T, KINOSHITA T, SAIURA A, et al. Multicentre analysis of long-term outcome after surgical resection for gastric cancer liver metastases[J]. Br J Surg, 2015, 102(1): 102-107.
doi: 10.1002/bjs.9684
pmid: 25389030
|
[20] |
TIBERIO G A, MINISTRINI S, GARDINI A, et al. Factors influencing survival after hepatectomy for metastases from gastric cancer[J]. Eur J Surg Oncol, 2016, 42(8): 1229-1235.
doi: 10.1016/j.ejso.2016.03.030
pmid: 27134189
|
[21] |
UGGERI F, RIPAMONTI L, PINOTTI E, et al. Is there a role for treatment-oriented surgery in liver metastases from gastric cancer?[J]. World J Clin Oncol, 2020, 11(7): 477-494.
doi: 10.5306/wjco.v11.i7.477
pmid: 32821653
|
[22] |
CHEN J, TANG Z, DONG X, et al. Radiofrequency ablation for liver metastasis from gastric cancer[J]. Eur J Surg Oncol, 2013, 39(7): 701-706.
doi: 10.1016/j.ejso.2013.03.023
pmid: 23597495
|
[23] |
ZHANG K C, CHEN L. Chinese consensus on the diagnosis and treatment of gastric cancer with liver metastases[J]. Ther Adv Med Oncol, 2020, 12: 1758835920904803.
|
[24] |
KATAOKA K, KINOSHITA T, MOEHLER M, et al. Current management of liver metastases from gastric cancer: what is common practice? New challenge of EORTC and JCOG[J]. Gastric Cancer, 2017, 20(5): 904-912.
doi: 10.1007/s10120-017-0696-7
pmid: 28150070
|
[25] |
VIGANÒ L, VELLONE M, FERRERO A, et al. Liver resection for gastric cancer metastases[J]. Hepato-gastroenterology, 2013, 60(123): 557-562.
pmid: 23635434
|
[26] |
YUKAMI H, KAWAZOE A, LIN Y T, et al. Updated efficacy outcomes of anti-PD-1 antibodies plus multikinase inhibitors for patients with advanced gastric cancer with or without liver metastases in clinical trials[J]. Clin Cancer Res, 2022, 28(16): 3480-3488.
doi: 10.1158/1078-0432.CCR-22-0630
pmid: 35679062
|